Myristoylated Alanine-Rich C Kinase Substrate Accelerates TNF-α-Induced Apoptosis in SH-SY5Y Cells in a Caspases-6 and/or -7-Dependent Manner


Cell proliferation, differentiation, and the elimination of unnecessary cells by apoptosis occur in the development of the nervous system. It is reported that brain dysplasia appears as the results of myristoylated alanine-rich C kinase substrate (MARCKS) knockout or the mutant mouse. We therefore expect that MARCKS participates in the development of the nervous system. However, the mechanism underlying such participation has not been identified. In this study, we observed the effects of the overexpression of MARCKS or unphosphorylatable MARCKS on cell proliferation and TNF-α-induced apoptosis in neuroblastoma SH-SY5Y cells. Furthermore, we restrained MARCKS expression by the RNAi method. In the results, MARCKS-overexpressing cells and not unphosphorylatable MARCKS-overexpressing cells showed increased cell proliferation rates. On the other hand, the RNAi decreased the proliferation of MARCKS-knocked down SH-SY5Y cells. These results indicated that MARCKS-overexpressing cells were more sensitive to TNF-α than normal SH-SY5Y cells. Moreover, in MARCKS-overexpressing cells TNF-α-induced apoptosis was inhibited by caspase-6 and -7 inhibitors but not by caspase-3 inhibitor. These results suggested that MARCKS participated in TNF-α-induced apoptosis in a caspase-6 and/or -7-dependent manner.

Share and Cite:

Tanabe, A. , Shiraishi, M. and Sasaki, Y. (2015) Myristoylated Alanine-Rich C Kinase Substrate Accelerates TNF-α-Induced Apoptosis in SH-SY5Y Cells in a Caspases-6 and/or -7-Dependent Manner. Advances in Bioscience and Biotechnology, 6, 572-582. doi: 10.4236/abb.2015.68060.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Nagumo, H., Ikenoya, M., Sakurada, K., Furuya, K., Ikuhara, T., Hiraoka, H. and Sasaki, Y. (2001) Rho-Associated Kinase Phosphorylates MARCKS in Human Neuronal Cells. Biochemical and Biophysical Research Communications, 280, 605-609.
[2] Tanabe, A., Kamisuki, Y., Hidaka, H., Suzuki, M., Negishi, M. and Takuwa, Y. (2006) PKC Phosphorylates MARCKS Ser159 Not Only Directly but Also through RhoA/ROCK. Biochemical and Biophysical Research Communications, 345, 156-161.
[3] Zhao, Y., Neltner, B.S. and Davis, H.W. (2000) Role of MARCKS in Regulating Endothelial Cell Proliferation. American Journal of Physiology—Cell Physiology, 279, C1611-C1620.
[4] Blackshear, P.J. (1993) The MARCKS Family of Cellular Protein Kinase C Substrates. Journal of Biological Chemistry, 268, 1501-1504.
[5] McLaughlin, S. and Aderem, A. (1995) The Myristoyl-Electrostatic Switch: A Modulator of Reversible Protein-Membrane Interactions. Trends in Biochemical Sciences, 20, 272-276.
[6] Elzagallaai, A., Rose, S.D. and Trifaro, J.M. (2000) Platelet Secretion Induced by Phorbol Esters Stimulation Is Mediated through Phosphorylation of MARCKS: A MARCKS-Derived Peptide Blocks MARCKS Phosphorylation and Serotonin Release without Affecting Pleckstrin Phosphorylation. Blood, 95, 894-902.
[7] Hartwig, J.H., Thelen, M., Rosen, A., Janmey, P.A., Nairn, A.C. and Aderem, A. (1992) MARCKS Is an Actin Filament Crosslinking Protein Regulated by Protein Kinase C and Calcium-Calmodulin. Nature, 356, 618-622.
[8] Wang, J., Arbuzova, A., Hangyás-Mihályné, G. and McLaughlin, S. (2001) The Effector Domain of Myristoylated Alanine-Rich C Kinase Substrate Binds Strongly to Phosphatidylinositol 4,5-Bisphosphate. Journal of Biological Chemistry, 276, 5012-5019.
[9] Stumpo, D.J., Bock, C.B., Uttle, J.S. and Blackshear, P.J. (1995) MARCKS Deficiency in Mice Leads to Abnormal Brain Development and Perinatal Death. Proceedings of the National Academy of Sciences of the United States of America, 92, 944-948.
[10] Cowan, V.M., Fawcett, J.W., O’Leary, D.D.M. and Stanfield, B.B. (1984) Regressive Events in Neurogenesis. Science, 225, 1258-1265.
[11] Gruss, H.J. and Dower, S.K. (1995) Tumor Necrosis Factor Ligand Superfamily: Involvement in the Pathology of Malignant Lymphomas. Blood, 85, 3378-3404.
[12] Tanabe, A., Shiraishi, M., Negishi, M., Saito, N., Tanabe, M. and Sasaki, Y. (2012) MARCKS Dephosphorylation Is Involved in Bradykinin-Induced Neurite Outgrowth in Neuroblastoma SH-SY5Y Cells. Journal of Cellular Physiology, 227, 618-629.
[13] McGill, C.J. and Brooks, G. (1997) Expression and Regulation of 80K/MARCKS, a Major Substrate of Protein Kinase C, in the Developing Rat Heart. Cardiovascular Research, 34, 368-376.
[14] Weimer, J.M., Yokota, Y., Stanco, A., Stumpo, D.J., Blackshear, P.J. and Anton, E.S. (2009) MARCKS Modulates Radial Progenitor Placement, Proliferation and Organization in the Developing Cerebral Cortex. Development, 136, 2965-2975.
[15] Manenti, S., Malecaze, F., Chap, H. and Darbon, J.M. (1998) Overexpression of the Myristoylated Alanine-Rich C Kinase Substrate in Human Choroidal Melanoma Cells Affects Cell Proliferation. Cancer Research, 58, 1429-1434.
[16] Yang, M., Wu, S., Su, X. and May, W.S. (2006) JAZ Mediates G1 Cell-Cycle Arrest and Apoptosis by Positively Regulating p53 Transcriptional Activity. Blood, 108, 4136-4145.
[17] Conzen, S.D., Gottlob, K., Kandel, E.S., Khanduri, P., Wagner, A.J., O’Leary, M. and Hay, N. (2000) Induction of Cell Cycle Progression and Acceleration of Apoptosis Are Two Separable Functions of c-Myc: Transrepression Correlates with Acceleration of Apoptosis. Molecular and Cellular Biology, 20, 6008-6018.
[18] Padmanabhan, J., Park, D.S., Greene, L.A. and Shelanski, M.L. (1999) Role of Cell Cycle Regulatory Proteins in Cerebellar Granule Neuron Apoptosis. The Journal of Neuroscience, 19, 8747-8756.
[19] Monahan, T.S., Andersen, N.D., Martin, M.C., Malek, J.Y., Shrikhande, G.V., Pradhan, L., Ferran, C. and LoGerfo, F.W. (2009) MARCKS Silencing Differentially Affects Human Vascular Smooth Muscle and Endothelial Cell Phenotypes to Inhibit Neointimal Hyperplasia in Saphenous Vein. The FASEB Journal, 23, 557-564.
[20] McGill, C.J. and Brooks, G. (1997) Expression and Regulation of 80K/MARCKS, a Major Substrate of Protein Kinase C, in the Developing Rat Heart. Cardiovascular Research, 34, 368-376.
[21] Laouar, A., Glesne, D. and Huberman, E. (1999) Involvement of Protein Kinase C-β and Ceramide in Tumor Necrosis Factor-α-Induced but Not Fas-Induced Apoptosis of Hu-man Myeloid Leukemia Cells. The Journal of Biological Chemistry, 274, 23526-23534.
[22] Chang, Q. and Tepperman, B.L. (2001) The Role of Protein Kinase C Isozymes in TNF-Alpha-Induced Cytotoxicity to a Rat Intestinal Epithelial Cell Line. American Journal of Physiology—Gastrointestinal and Liver Physiology, 280, G572-G583.
[23] Comalada, M., Xaus, J., Valledor, A.F., López-López, C., Pennington, D.J. and Celada, A. (2003) PKC Epsilon Is Involved in JNK Activation That Mediates LPS-Induced TNF-Alpha, Which Induces Apoptosis in Macrophages. American Journal of Physiology—Cell Physiology, 285, C1235-C1245.
[24] Mong, P.Y., Petrulio, C., Kaufman, H.L. and Wang, Q. (2008) Activation of Rho Kinase by TNF-Alpha Is Required for JNK Activation in Human Pulmonary Microvascular Endothelial Cells. The Journal of Immunology, 180, 550-558.
[25] Ho, A.W., Wong, C.K. and Lam, C.W. (2008) Tumor Necrosis Factor-Alpha Up-Regulates the Expression of CCL2 and Adhesion Molecules of Human Proximal Tubular Epithelial Cells through MAPK Signaling Pathways. Immunobiology, 213, 533-544.
[26] Okuma-Yoshioka, C., Seto, H., Kadono, Y., Hikita, A., Oshima, Y., Kurosawa, H., Nakamura, K. and Tanaka, S. (2008) Tumor Necrosis Factor-Alpha Inhibits Chondrogenic Differentiation of Synovial Fibroblasts through p38 Mitogen Activating Protein Kinase Pathways. Modern Rheumatology, 18, 366-378.
[27] Lin, C.C., Tseng, H.W., Hsieh, H.L., Lee, C.W., Wu, C.Y., Cheng, C.Y. and Yang, C.M. (2008) Tumor Necrosis Factor-Alpha Induces MMP-9 Expression via p42/p44 MAPK, JNK, and Nuclear Factor-kappaB in A549 Cells. Toxicology and Applied Pharmacology, 15, 386-398.
[28] O’Sullivan, A.W., Wang, J.H. and Redmond, H.P. (2009) The Role of P38 MAPK and PKC in BLP Induced TNF-Alpha Release, Apoptosis, and NFkappaB Activation in THP-1 Monocyte Cells. Journal of Surgical Research, 151, 138-144.
[29] Iyer, C., Kosters, A., Sethi, G., Kunnumakkara, A.B., Aggarwal, B.B. and Versalovic, J (2008) Probiotic Lactobacillus Reuteri Promotes TNF-Induced Apoptosis in Human Myeloid Leukemia-Derived Cells by Modulation of NF-kappaB and MAPK Signalling. Cellular Microbiology, 10, 1442-1452.
[30] Ohmitsu, M., Fukunaga, K., Yamamoto, H. and Miyamoto, E. (1999) Phosphorylation of Myristoylated Alanine-Rich Protein Kinase C Substrate by Mitogen-Activated Protein Kinase in Cultured Rat Hippocampal Neurons Following Stimulation of Glutamate Receptors. The Journal of Biological Chemistry, 274, 408-417.
[31] Nwariaku, F.E., Rothenbach, P., Liu, Z., Zhu, X., Turnage, R.H. and Terada, L.S. (2003) Rho Inhibition Decreases TNF-Induced Endothelial MAPK Activation and Monolayer Permeability. Journal of Applied Physiology, 95, 1889-1895.
[32] Disatnik, M.H., Boutet, S.C., Lee, C.H., Mochly-Rosen, D. and Rando, T.A. (2002) Sequential Activation of Individual PKC Isozymes in Integrin-Mediated Muscle Cell Spreading: A Role for MARCKS in an Integrin Signaling Pathway. Journal of Cell Science, 115, 2151-2163.
[33] Fukushima, K., Miyamoto, S., Komatsu, H., Tsukimori, K., Kobayashi, H., Seki, H., Takeda, S. and Nakano, H. (2003) TNFα Induced Apoptosis and Integrin Switching in Human Extravillous Trophoblast Cell Line. Biology of Reproduction, 68, 1771-1778.
[34] Thelen, M., Rosen, A., Nairn, A.C. and Aderem, A. (1990) Tumor Necrosis Factor Alpha Modifies Agonist-Dependent Responses in Human Neutrophils by Inducing the Synthesis and Myristoylation of a Specific Protein Kinase C Substrate. Proceedings of the National Academy of Sciences of the United States of America, 87, 5603-5607.
[35] Stein, J., Volk, H.D., Liebenthal, C.L., Krüger, D.H. and Prüsch, S. (1993) Tumour Necrosis Factor α Stimulates the Activity of the Human Cytomegalovirus Major Immediate Early Enhancer/Promoter in Immature Monocytic Cells. Journal of General Virology, 74, 2333-2338.
[36] Mandal, D., Baudin-Creuza, V., Bhattacharyya, A., Pathak, S., Delaunay, J., Kundu, M. and Basu, J. (2003) Caspase 3-Mediated Proteolysis of the N-Terminal Cytoplasmic Domain of the Human Erythroid Anion Exchanger 1 (Band 3). The Journal of Biological Chemistry, 278, 52551-52558.
[37] Talanian, R.V., Dang, L.C., Ferenz, C.R., Hackett, M.C., Mankovich, J.A., Welch, J.P., Wong, W.W. and Brady, K.D. (1996) Stability and Oligomeric Equilibria of Refolded Interleukin-1β Converting Enzyme. The Journal of Biological Chemistry, 271, 21853-21858.
[38] Wilson, K.P., Black, J.A., Thomson, J.A., Kim, E.E., Griffith, J.P., Navia, M.A., Murcko, M.A., Chambers, S.P., Aldape, R.A. and Raybuck, S.A. (1994) Structure and Mechanism of Interleu-kin-1 Beta Converting Enzyme. Nature, 370, 270-275.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.